These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2126502)

  • 1. Skin acceptance of transcutaneous nitroglycerin patches: a prospective study of 33 patients.
    Vaillant L; Biette S; Machet L; Constans T; Monpère C
    Contact Dermatitis; 1990 Sep; 23(3):142-5. PubMed ID: 2126502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance of transcutaneous nitroglycerin patches by patients with angina pectoris.
    Schrader BJ; Bauman JL; Zeller FP; Shanes JG; Rich S
    Pharmacotherapy; 1986; 6(2):83-6. PubMed ID: 3086849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe allergic contact dermatitis secondary to nitroglycerin in a transdermal therapeutic system.
    Topaz O; Abraham D
    Ann Allergy; 1987 Nov; 59(5):365-6. PubMed ID: 3120627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal contact dermatitis to nitroderm TTS 5 with extensive postinflammatory hypermelanosis.
    Harari Z; Sommer I; Knobel B
    Dermatologica; 1987; 174(5):249-52. PubMed ID: 2953633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupational allergic contact dermatitis caused by nitroglycerin.
    Kanerva L; Laine R; Jolanki R; Tarvainen K; Estlander T; Helander I
    Contact Dermatitis; 1991 May; 24(5):356-62. PubMed ID: 1832616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic reactions to local glyceryl trinitrate administration.
    Kounis NG; Zavras GM; Papadaki PJ; Soufras GD; Poulos EA; Goudevenos J; Alangoussis A; Antonakopoulos K; Frangides C; Peristeropoulou SA; Koutsojannis C
    Br J Clin Pract; 1996 Dec; 50(8):437-9. PubMed ID: 9039714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contact allergy to glycerol trinitrate (nitroderm TTS)].
    Weickel R; Frosch PJ
    Hautarzt; 1986 Sep; 37(9):511-2. PubMed ID: 2945802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse dermatologic reaction to transdermal nitroglycerin.
    Letendre PW; Barr C; Wilkens K
    Drug Intell Clin Pharm; 1984 Jan; 18(1):69-70. PubMed ID: 6420136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic contact dermatitis secondary to topical nitroglycerin.
    Sausker WF; Frederick FD
    JAMA; 1978 Apr; 239(17):1743-4. PubMed ID: 416235
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic contact dermatitis from nitroglycerin contained in 2 transdermal systems.
    Machet L; Martin L; Toledano C; Jan V; Lorette G; Vaillant L
    Dermatology; 1999; 198(1):106-7. PubMed ID: 10026420
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic contact dermatitis from transdermal nitroglycerin.
    Carmichael AJ; Foulds IS
    Contact Dermatitis; 1989 Aug; 21(2):113-4. PubMed ID: 2530050
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact dermatitis from nitroglycerin.
    de la Fuente Prieto R; Armentia Medina A; Diez Perez JM
    Ann Allergy; 1994 Apr; 72(4):344-6. PubMed ID: 8154634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic and nonallergic reactions to nitroglycerin.
    Ramey JT; Lockey RF
    Allergy Asthma Proc; 2006; 27(3):273-80. PubMed ID: 16913273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic contact dermatitis secondary to transdermal nitroglycerin.
    Rosenfeld AS; White WB
    Am Heart J; 1984 Oct; 108(4 Pt 1):1061-2. PubMed ID: 6237565
    [No Abstract]   [Full Text] [Related]  

  • 15. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
    Parker JD; Parker AB; Farrell B; Parker JO
    Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with a transdermal nitroglycerin system.
    Mahapatra RK; Mahapatra D; Yaden S
    Angiology; 1987 Apr; 38(4):277-86. PubMed ID: 3107441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of contact dermatitis associated with transdermal therapeutic systems.
    Holdiness MR
    Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe contact dermatitis due to nitroglycerin patches.
    Fischer RG; Tyler M
    South Med J; 1985 Dec; 78(12):1523-4. PubMed ID: 3934763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of angina pectoris with nitroglycerin plasters. A multicenter study involving 6,986 patients.
    Agabiti Rosei E; Muiesan ML; Pollavini G; Bichisao E; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):572-81. PubMed ID: 3123406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.